Cargando…
Genetic architecture of human fibrotic diseases: disease risk and disease progression
Genetic studies of human diseases have identified multiple genetic risk loci for various fibrotic diseases. This has provided insights into the myriad of biological pathways potentially involved in disease pathogenesis. These discoveries suggest that alterations in immune responses, barrier function...
Autores principales: | Gardet, Agnès, Zheng, Timothy S., Viney, Joanne L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866586/ https://www.ncbi.nlm.nih.gov/pubmed/24391588 http://dx.doi.org/10.3389/fphar.2013.00159 |
Ejemplares similares
-
Are mast cells instrumental for fibrotic diseases?
por: Overed-Sayer, Catherine, et al.
Publicado: (2014) -
A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease
por: Fang, Lu, et al.
Publicado: (2017) -
Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
por: Zhu, Yi, et al.
Publicado: (2022) -
Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy
por: Kasam, Rajesh K., et al.
Publicado: (2019) -
Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017)